EP2394648
Lyfjafræðileg samsetning til inntöku
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.2.2010EP published:
31.8.2016EP application number:
10738504.9
EP translation filed:
15.9.2016Grant published:
15.10.2016EPO information:
European Patent Register
Max expiry date:
1.2.2030Expiry date:
1.2.2027Next due date:
28.2.2027
Title:
PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
Timeline
Today
2.2.2010EP application
31.8.2016EP Publication
15.9.2016Translation submitted
15.10.2016Registration published
1.2.2027Expires
Owner
Name:
Astellas Pharma Inc.Address:
5-1, Nihonbashi-Honcho 2-chome, 103-8411, Chuo-kuTokyo, JP
Inventor
Name:
YASUJI TakehikoAddress:
Tokyo, JP
Name:
KINOSHITA NoriyukiAddress:
Tokyo, JP
Name:
YOSHINO HiroyukiAddress:
Tokyo, JP
Name:
KAWAHAMA ShuuyaAddress:
Tokyo, JP
Name:
SAKO KazuhiroAddress:
Tokyo, JP
Name:
SUGIHARA AkioAddress:
Yaizu-shiShizuoka, JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
149854 PDate:
4.2.2009Country:
US
Classification
Categories:
A61K 31/439, A61K 31/18, A61K 47/10, A61K 47/26, A61K 47/32, A61K 47/38, A61P 13/02, A61P 13/08, A61K 9/20, A61K 9/48, A61K 31/47
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 9.1.2017
Expires: 1.2.2018
Payer: Árnason Faktor
Number: 9
Paid: 8.1.2018
Expires: 1.2.2019
Payer: Árnason Faktor
Number: 10
Paid: 9.1.2019
Expires: 1.2.2020
Payer: Árnason Faktor
Number: 11
Paid: 14.1.2020
Expires: 1.2.2021
Payer: Árnason Faktor ehf.
Number: 12
Paid: 12.1.2021
Expires: 1.2.2022
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.1.2022
Expires: 1.2.2023
Payer: Árnason Faktor ehf.
Number: 14
Paid: 19.1.2023
Expires: 1.2.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 18.1.2024
Expires: 1.2.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 20.1.2025
Expires: 1.2.2026
Payer: Árnason Faktor ehf.
Number: 17
Paid: 30.1.2026
Expires: 1.2.2027
Payer: Árnason Faktor ehf.